Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing, and Streptococcal Infections and Treatments.
Impact of SARS-CoV-2 exposure history on antibody kinetics and correlates of protection in The Gambia
Impact of SARS-CoV-2 exposure history on antibody kinetics and correlates of protection in The Gambia
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging.
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee.
Mucosal IgA to pre-fusion F protein predicts protection from RSV infection in a high burden setting
Molecular analysis of Lancefield group C/G streptococci causing human infections in Sheffield, UK
Unique nasal cell states induced by common pediatric respiratory viruses
Prevalence and risk factors for Staphylococcus aureus colonisation among healthy individuals in low- and middle-income countries: A systematic review and meta-analysis
Prevalence and risk factors for Staphylococcus aureus colonisation among healthy individuals in low- and middle-income countries: A systematic review and meta-analysis.
Molecular Methods Enhance the Detection of Pyoderma-Related Streptococcus pyogenes and emm-Type Distribution in Children.
Compartmentalised mucosal and blood immunity to SARS-CoV-2 is associated with high seroprevalence before the Delta wave in Africa
Integrative mapping of preexisting influenza immune landscapes predicts vaccine response
Evaluating clinical decision rules and rapid diagnostic tests for the diagnosis of Streptococcus pyogenes pharyngitis in Gambian children: A diagnostic accuracy study
Evaluating clinical decision rules and rapid diagnostic tests for the diagnosis of Streptococcus pyogenes pharyngitis in Gambian children: A diagnostic accuracy study
serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting
Household Molecular Epidemiology of <i>Streptococcus pyogenes</i> Carriage and Infection in The Gambia
Effect of intrapartum azithromycin on early childhood gut mycobiota development: post hoc analysis of a double-blind randomized trial.
Compartmentalised mucosal and blood immunity to SARS-CoV-2 is associated with high seroprevalence before the Delta wave in Africa.
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.
Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress
<i>serojump</i>
: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data
Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.
Integrative Mapping of Pre-existing Immune Landscapes for Vaccine Response Prediction
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal immunity– an observational cohort study
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia.